Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis.

Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, Zvaifler NJ, Green DR, Firestein GS.

Am J Pathol. 2002 Jan;160(1):123-30.

2.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

3.

The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.

Leech M, Xue JR, Dacumos A, Hall P, Santos L, Yang Y, Li M, Kitching AR, Morand EF.

Clin Exp Immunol. 2008 May;152(2):345-53. doi: 10.1111/j.1365-2249.2008.03629.x. Epub 2008 Mar 12.

4.

Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.

Tada Y, Koarada S, Morito F, Ushiyama O, Haruta Y, Kanegae F, Ohta A, Ho A, Mak TW, Nagasawa K.

Arthritis Rheum. 2003 Nov;48(11):3280-90.

5.

Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis.

van Lent PL, Holthuysen AE, van den Bersselaar LA, van Rooijen N, Joosten LA, van de Loo FA, van de Putte LB, van den Berg WB.

Arthritis Rheum. 1996 Sep;39(9):1545-55.

PMID:
8814067
6.
7.

Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA).

Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN.

Clin Exp Immunol. 1997 Mar;107(3):507-12.

8.

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.

Arthritis Rheum. 2005 Oct;52(10):3239-47.

9.

A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis.

Abreu JR, Dontje W, Krausz S, de Launay D, van Hennik PB, van Stalborch AM, Ten Klooster JP, Sanders ME, Reedquist KA, Vervoordeldonk MJ, Hordijk PL, Tak PP.

Arthritis Res Ther. 2010;12(1):R2. doi: 10.1186/ar2900. Epub 2010 Jan 6.

10.

Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.

Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, Kay GF.

Arthritis Rheum. 2003 Sep;48(9):2660-9.

11.

Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.

Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, David JR, Bucala R, Morand EF.

Arthritis Rheum. 2003 Jul;48(7):1881-9.

12.

Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.

Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.

Arthritis Res Ther. 2006;8(4):R132.

13.

Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.

Geng H, Carlsen S, Nandakumar KS, Holmdahl R, Aspberg A, Oldberg A, Mattsson R.

Arthritis Res Ther. 2008;10(6):R134. doi: 10.1186/ar2551. Epub 2008 Nov 14.

14.

Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.

Ross AD, Banda NK, Muggli M, Arend WP.

Arthritis Rheum. 2004 Nov;50(11):3702-11.

15.

[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].

Seemayer CA, Distler O, Kuchen S, Müller-Ladner U, Michel BA, Neidhart M, Gay RE, Gay S.

Z Rheumatol. 2001 Oct;60(5):309-18. Review. German.

PMID:
11759230
16.

Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.

Jin CH, Chae SY, Kim TH, Yang HK, Lee EY, Song YW, Jo DG, Lee KC.

J Pharmacol Exp Ther. 2010 Mar;332(3):858-65. doi: 10.1124/jpet.109.159517. Epub 2009 Nov 20.

17.

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Feb;50(2):650-9.

18.

The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.

Bessis N, Guéry L, Mantovani A, Vecchi A, Sims JE, Fradelizi D, Boissier MC.

Eur J Immunol. 2000 Mar;30(3):867-75.

19.
20.

Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.

Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, Fugger L.

J Immunol. 2004 Dec 1;173(11):7037-45.

Supplemental Content

Support Center